Heart Vascular Function and Thyroid Hormone Receptors

心脏血管功能和甲状腺激素受体

基本信息

  • 批准号:
    8696825
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-07-01 至 2015-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Ischemic heart disease continues to be a significant medical problem and approaches other than coronary artery revascularization have had no long term success to improve myocardial perfusion. Hyperthyroidism increases coronary perfusion and enhances cardiac capillary density but these beneficial vascular effects are accompanied by undesirable cardiac changes like increases in heart rate and cardiac O2 consumption. It is currently unclear if increasing the expression of thyroid hormone receptor (TR) isoforms TR1 or TR2 only in vascular endothelial cells (ECs) can result in beneficial vascular effects in the absence of undesirable cardiac or systemic changes. In addition the detailed mechanisms by which TR isoforms exert their effects in ECs are largely unexplored. We generated mice with EC specific expression or deletion of TR1 and TR2 to explore effects on vascular function with a focus on coronary perfusion and cardiac capillary density. In Aim I we explore if changes in TR1 or TR2 expression in ECs effects vascular function especially coronary perfusion and coronary artery contraction and relaxation. In addition we identify mechanisms which mediate these changes. Preliminary results show that increased expression of TR11 in ECs leads to a marked increase in coronary perfusion in the absence of undesirable effects like increases in heart rate, oxygen consumption, or a significant decrease in systemic vascular resistance. In Aim II we determine the effects of EC-based TR1 and TR2 expression or deletion on cardiac capillary density. Our preliminary data show that changes of TR2 expression in ECs exerts selective effects markedly increasing cardiac capillary density with no effect by TR1. In Aim III we determine if increasing TR1 or TR2 expression in ECs and restoring ischemia reperfusion (I/R) mediated decreases in TR levels ameliorates I/R mediated cardiac injury. Preliminary results show that exposing hearts or ECs to I/R like conditions significantly lowers EC TR levels. In addition we find that increasing TR expression in ECs ameliorates I/R mediated injury and decreases infarct size under in vivo conditions. The studies may lead to novel approaches to improve coronary perfusion and increase substrate exchange by increasing cardiac capillary density in the absence of undesirable effects. In addition new knowledge related to TR action in ECs will be obtained. POTENTIAL IMPACT ON VETERANS HEALTH CARE: Ischemic heart disease significantly contributes to morbidity and mortality in the veteran patient population. The "preclinical" research of this proposal demonstrates significant improvement in cardiac microcirculatory function and decreased myocardial infarct size by expression of thyroid hormone receptors in vascular endothelial cells. These findings may lead to clinical translation in future approaches.
描述(由申请人提供):

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Wolfgang H Dillmann其他文献

Wolfgang H Dillmann的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Wolfgang H Dillmann', 18)}}的其他基金

Heart Function Decline and Aging
心脏功能衰退与衰老
  • 批准号:
    10427227
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Heart Function Decline and Aging
心脏功能衰退与衰老
  • 批准号:
    10265347
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Heart Vascular Function and Thyroid Hormone Receptors
心脏血管功能和甲状腺激素受体
  • 批准号:
    8140390
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
Heart Vascular Function and Thyroid Hormone Receptors
心脏血管功能和甲状腺激素受体
  • 批准号:
    8262605
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
MECHANISM OF DIABETIC CARDIOMYOPATHY
糖尿病心肌病的机制
  • 批准号:
    8361919
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
Heart Vascular Function and Thyroid Hormone Receptors
心脏血管功能和甲状腺激素受体
  • 批准号:
    8398969
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
MECHANISM OF DIABETIC CARDIOMYOPATHY
糖尿病心肌病的机制
  • 批准号:
    8169620
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
THYROID ACTION IN THE HEART
甲状腺在心脏中的作用
  • 批准号:
    7957622
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
MECHANISM OF DIABETIC CARDIOMYOPATHY
糖尿病心肌病的机制
  • 批准号:
    7957630
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
MECHANISM OF DIABETIC CARDIOMYOPATHY
糖尿病心肌病的机制
  • 批准号:
    7722464
  • 财政年份:
    2008
  • 资助金额:
    --
  • 项目类别:

相似海外基金

A cluster randomized controlled trial to evaluate pharmacy-based health promotion program to improve blood pressure control in Bangladesh, India and Pakistan
一项整群随机对照试验,旨在评估孟加拉国、印度和巴基斯坦基于药房的健康促进计划,以改善血压控制
  • 批准号:
    23K24566
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Defining a new mechanism of blood pressure regulation and its role during sepsis
定义血压调节的新机制及其在脓毒症期间的作用
  • 批准号:
    MR/Y011805/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Cuffless models to infer blood pressure from bioimpedance
无袖带模型可根据生物阻抗推断血压
  • 批准号:
    2319920
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Blood pressure trajectory of inpatient rehabilitation stroke patients from the Determining Optimal Post-Stroke Exercise (DOSE) trial over the first 12-months post-stroke
通过确定最佳中风后运动 (DOSE) 试验得出的中风住院康复患者在中风后 12 个月内的血压轨迹
  • 批准号:
    493123
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
AirPressureNYC: Reducing AIR pollution to lower blood PRESSURE among New York City public housing residents
AirPressureNYC:减少空气污染以降低纽约市公共住房居民的血压
  • 批准号:
    10638946
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
The mechanism of non-dipper blood pressure induced by intermittent hypoxia during sleep
睡眠间歇性缺氧引起非杓型血压的机制
  • 批准号:
    23K06336
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Machine Learning Enabled Non-contact Sensing Platform for Blood Pressure and Glucose Prediction
用于血压和血糖预测的机器学习非接触式传感平台
  • 批准号:
    23K11341
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
I-Corps: Blood Pressure Monitoring by a Miniaturized Cuffless Sensor
I-Corps:通过小型无袖带传感器进行血压监测
  • 批准号:
    2332674
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Blood pressure imaging by contrast enhanced active Doppler ultrasound
通过对比增强主动多普勒超声进行血压成像
  • 批准号:
    23K18557
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Central Nervous System Reprogramming of the Control of Blood Pressure Induced by Early Life Stress
早期生活压力引起的血压控制的中枢神经系统重新编程
  • 批准号:
    10555126
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了